- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 261/16 - Benzene-sulfonamido isoxazoles
Patent holdings for IPC class C07D 261/16
Total number of patents in this class: 67
10-year publication summary
|
1
|
5
|
6
|
6
|
7
|
3
|
3
|
5
|
0
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Xenon Pharmaceuticals Inc. | 193 |
7 |
| Dompé Farmaceutici S.p.A. | 278 |
3 |
| Eastern Virginia Medical School | 68 |
3 |
| The Regents of the University of California, Santa Cruz | 18 |
3 |
| Thomas Jefferson University | 544 |
3 |
| Biofront Ltd. (Cayman) | 15 |
3 |
| Elara Pharmaceuticals GmbH | 9 |
2 |
| European Molecular Biology Laboratory (embl) | 24 |
2 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 325 |
2 |
| Sanford-Burnham Medical Research Institute | 126 |
2 |
| Theaprin Pharmaceuticals Inc. | 33 |
2 |
| Shanghai Hansoh Biomedical Co., Ltd. | 291 |
2 |
| Nissan Chemical Corporation | 2110 |
2 |
| The Royal Institution for The Advancement of Learning / McGill University | 715 |
2 |
| The United States of America Department of Health | 2 |
2 |
| Novartis Pharma AG | 102 |
1 |
| Boehringer Ingelheim International GmbH | 4636 |
1 |
| Centre National de La Recherche Scientifique | 10706 |
1 |
| Vertex Pharmaceuticals Incorporated | 1630 |
1 |
| Curegenix, Inc. | 16 |
1 |
| Other owners | 22 |